(Q53622009)

16 May 2018

title

Primary CCR5 only using HIV-1 isolates does not accurately represent the in vivo replicating quasi-species. (English)

1 reference

16 May 2018

author name string

Marlén M I Aasa-Chapman

1

1 reference

16 May 2018

Keith Aubin

2

1 reference

16 May 2018

Ian Williams

3

1 reference

16 May 2018

Aine McKnight

4

1 reference

16 May 2018

language of work or name

English

0 references

publication date

19 May 2006

1 reference

16 May 2018

published in

Virology

1 reference

16 May 2018

volume

351

1 reference

16 May 2018

issue

2

1 reference

16 May 2018

page(s)

489-496

1 reference

16 May 2018

Development of the antibody response in acute HIV-1 infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV-1 receptors and cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Cell surface receptors, virus entry and tropism of primate lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Expression cloning of new receptors used by simian and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV-1 tropism and co-receptor use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

The biological phenotype of HIV-1 is usually retained during and after sexual transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Chemokine receptors in HIV-1 infection of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Malaria enhances expression of CC chemokine receptor 5 on placental macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.04.002

1 reference

16 May 2018

1 reference

16 May 2018